Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
This grant opportunity invites applications aimed at adapting and clinically validating molecular, cellular, or imaging markers to improve cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction, as well as cancer prevention and control. It supports obtaining well-documented specimens from NCI-supported or other clinical trials or observational cohorts for validat…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The applicants should propose projects that are expected to accelerate the pace of tran…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Special program…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers